Healthcare Triangle is trading 6.06% down in pre-market at $0.57 after Nasdaq’s October 1, 2026 delisting determination. - Nasdaq cited the company’s failure to meet the $1 minimum bid-price rule; recent reverse splits made it ineligible for a standard compliance period. - The company intends to appeal; an October 8 request would stay suspension during hearings. - The notice has no immediate effect on trading; absent appeal, suspension is set for October 12. No separate October 6 announcement was identified; major U.S. indexes were higher.